vs
Absci Corp（ABSI）与OneMedNet Corp（ONMD）财务数据对比。点击上方公司名可切换其他公司
OneMedNet Corp的季度营收约是Absci Corp的1.4倍（$890.0K vs $650.0K）。OneMedNet Corp净利率更高（-352.8% vs -4548.0%，领先4195.2%）。OneMedNet Corp同比增速更快（3323.1% vs -2.3%）。OneMedNet Corp自由现金流更多（$-1.7M vs $-29.3M）。过去两年OneMedNet Corp的营收复合增速更高（89.4% vs -14.9%）
Absci Corp是一家结合合成生物学与人工智能技术的生物技术企业，为全球制药及生物制药合作伙伴提供集成式蛋白质工程解决方案，加速抗体、治疗性蛋白等新型生物候选药物的研发，助力满足未被覆盖的临床医疗需求。
OneMedNet Corp是一家总部位于美国的医疗科技企业，提供面向医学影像与患者健康信息的安全云数据共享及工作流解决方案，服务覆盖医疗机构、支付方及生命科学领域机构，核心运营市场为北美地区。
ABSI vs ONMD — 直观对比
营收规模更大
ONMD
是对方的1.4倍
$650.0K
营收增速更快
ONMD
高出3325.3%
-2.3%
净利率更高
ONMD
高出4195.2%
-4548.0%
自由现金流更多
ONMD
多$27.6M
$-29.3M
两年增速更快
ONMD
近两年复合增速
-14.9%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $650.0K | $890.0K |
| 净利润 | $-29.6M | $-3.1M |
| 毛利率 | — | 20.7% |
| 营业利润率 | -4775.5% | -353.4% |
| 净利率 | -4548.0% | -352.8% |
| 营收同比 | -2.3% | 3323.1% |
| 净利润同比 | -2.0% | -32.3% |
| 每股收益（稀释后） | $-0.19 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABSIONMD
| Q4 25 | $650.0K | $890.0K | ||
| Q3 25 | $378.0K | $177.0K | ||
| Q2 25 | $593.0K | $155.0K | ||
| Q1 25 | $1.2M | $137.0K | ||
| Q4 24 | $665.0K | $26.0K | ||
| Q3 24 | $1.7M | $142.0K | ||
| Q2 24 | $1.3M | $227.0K | ||
| Q1 24 | $898.0K | $248.0K |
净利润ABSIONMD
| Q4 25 | $-29.6M | $-3.1M | ||
| Q3 25 | $-28.7M | $-741.0K | ||
| Q2 25 | $-30.6M | $3.0M | ||
| Q1 25 | $-26.3M | $-1.9M | ||
| Q4 24 | $-29.0M | $-2.4M | ||
| Q3 24 | $-27.4M | $-2.1M | ||
| Q2 24 | $-24.8M | $-3.6M | ||
| Q1 24 | $-22.0M | $-2.1M |
毛利率ABSIONMD
| Q4 25 | — | 20.7% | ||
| Q3 25 | — | -125.4% | ||
| Q2 25 | — | -155.5% | ||
| Q1 25 | — | -163.5% | ||
| Q4 24 | — | -100.0% | ||
| Q3 24 | — | -59.2% | ||
| Q2 24 | — | -44.9% | ||
| Q1 24 | — | -27.8% |
营业利润率ABSIONMD
| Q4 25 | -4775.5% | -353.4% | ||
| Q3 25 | -7977.2% | -1262.7% | ||
| Q2 25 | -5293.9% | -1331.0% | ||
| Q1 25 | -2351.9% | -1623.4% | ||
| Q4 24 | -4477.3% | -10438.5% | ||
| Q3 24 | -1698.7% | -1645.1% | ||
| Q2 24 | -2104.0% | -1081.1% | ||
| Q1 24 | -2616.7% | -847.2% |
净利率ABSIONMD
| Q4 25 | -4548.0% | -352.8% | ||
| Q3 25 | -7594.2% | -418.6% | ||
| Q2 25 | -5155.0% | 1923.9% | ||
| Q1 25 | -2234.6% | -1388.3% | ||
| Q4 24 | -4358.3% | -9126.9% | ||
| Q3 24 | -1610.7% | -1449.3% | ||
| Q2 24 | -1948.8% | -1581.1% | ||
| Q1 24 | -2447.1% | -850.4% |
每股收益（稀释后）ABSIONMD
| Q4 25 | $-0.19 | $-0.06 | ||
| Q3 25 | $-0.20 | $-0.01 | ||
| Q2 25 | $-0.24 | $0.07 | ||
| Q1 25 | $-0.21 | $-0.06 | ||
| Q4 24 | $-0.26 | $-0.07 | ||
| Q3 24 | $-0.24 | $-0.07 | ||
| Q2 24 | $-0.22 | $-0.14 | ||
| Q1 24 | $-0.22 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $144.3M | $585.0K |
| 总债务越低越好 | — | $220.0K |
| 股东权益账面价值 | $189.4M | $-3.0M |
| 总资产 | $216.3M | $2.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ABSIONMD
| Q4 25 | $144.3M | $585.0K | ||
| Q3 25 | $152.5M | $149.0K | ||
| Q2 25 | $38.0M | $122.0K | ||
| Q1 25 | $47.0M | $144.0K | ||
| Q4 24 | $112.4M | $172.0K | ||
| Q3 24 | $38.2M | $1.9M | ||
| Q2 24 | $42.9M | $407.0K | ||
| Q1 24 | $58.8M | $174.0K |
总债务ABSIONMD
| Q4 25 | — | $220.0K | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $2.3M | ||
| Q4 24 | $4.0M | $2.3M | ||
| Q3 24 | — | $2.3M | ||
| Q2 24 | — | $2.4M | ||
| Q1 24 | — | — |
股东权益ABSIONMD
| Q4 25 | $189.4M | $-3.0M | ||
| Q3 25 | $210.3M | $-3.9M | ||
| Q2 25 | $173.4M | $-3.8M | ||
| Q1 25 | $198.8M | $-16.6M | ||
| Q4 24 | $179.1M | $-15.9M | ||
| Q3 24 | $201.3M | $-14.3M | ||
| Q2 24 | $221.5M | $-19.2M | ||
| Q1 24 | $240.1M | $-15.7M |
总资产ABSIONMD
| Q4 25 | $216.3M | $2.2M | ||
| Q3 25 | $245.0M | $1.5M | ||
| Q2 25 | $209.9M | $2.3M | ||
| Q1 25 | $232.4M | $1.7M | ||
| Q4 24 | $213.6M | $3.7M | ||
| Q3 24 | $235.2M | $4.4M | ||
| Q2 24 | $255.5M | $1.0M | ||
| Q1 24 | $274.9M | $750.0K |
负债/权益比ABSIONMD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.02× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-29.2M | $-1.7M |
| 自由现金流经营现金流 - 资本支出 | $-29.3M | $-1.7M |
| 自由现金流率自由现金流/营收 | -4505.4% | -193.0% |
| 资本支出强度资本支出/营收 | 15.8% | 0.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-94.2M | — |
8季度趋势，按日历期对齐
经营现金流ABSIONMD
| Q4 25 | $-29.2M | $-1.7M | ||
| Q3 25 | $-25.0M | $-1.6M | ||
| Q2 25 | $-16.9M | $-2.3M | ||
| Q1 25 | $-21.8M | $-1.9M | ||
| Q4 24 | $-17.0M | $-2.0M | ||
| Q3 24 | $-20.7M | $-1.9M | ||
| Q2 24 | $-16.8M | $-1.5M | ||
| Q1 24 | $-17.9M | $-1.5M |
自由现金流ABSIONMD
| Q4 25 | $-29.3M | $-1.7M | ||
| Q3 25 | $-26.0M | — | ||
| Q2 25 | $-17.1M | $-2.3M | ||
| Q1 25 | $-21.9M | $-2.0M | ||
| Q4 24 | $-17.0M | $-2.0M | ||
| Q3 24 | $-20.8M | $-1.9M | ||
| Q2 24 | $-17.2M | $-1.5M | ||
| Q1 24 | — | $-1.6M |
自由现金流率ABSIONMD
| Q4 25 | -4505.4% | -193.0% | ||
| Q3 25 | -6876.5% | — | ||
| Q2 25 | -2883.0% | -1475.5% | ||
| Q1 25 | -1854.5% | -1425.5% | ||
| Q4 24 | -2554.4% | -7811.5% | ||
| Q3 24 | -1221.6% | -1346.5% | ||
| Q2 24 | -1352.4% | -663.9% | ||
| Q1 24 | — | -626.2% |
资本支出强度ABSIONMD
| Q4 25 | 15.8% | 0.6% | ||
| Q3 25 | 254.5% | 0.0% | ||
| Q2 25 | 37.6% | 1.9% | ||
| Q1 25 | 2.1% | 3.6% | ||
| Q4 24 | 3.5% | 134.6% | ||
| Q3 24 | 2.8% | 6.3% | ||
| Q2 24 | 26.2% | 0.4% | ||
| Q1 24 | 0.0% | 2.4% |
现金转化率ABSIONMD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.77× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
